highperformr logo

NantKwest's Overview

Total employees44
HeadquartersCulver City
Founded

NantKwest, Inc. was a pioneering, clinical-stage immunotherapy company dedicated to harnessing the innate power of the human immune system through natural killer (NK) cells. Their focus was on developing treatments for cancer, infectious diseases, and inflammatory conditions. NantKwest's proprietary 'off-the-shelf' activated NK (aNK) cell platform was engineered to identify and destroy cancerous and virally-infected cells. Founded by Dr. Patrick Soon-Shiong, the company aimed to be at the forefront of innovative cancer care. In March 2021, NantKwest completed a merger with ImmunityBio, Inc., combining their respective expertise and pipelines to advance a broad range of immunotherapeutic approaches.

Where is NantKwest's Headquarters?

HQ Function

Served as the central hub for NantKwest's corporate, administrative, and strategic operations. This included executive leadership, business development, financial management, and oversight of global research and development activities.

Notable Features:

The Culver City headquarters likely consisted of modern office spaces designed for executive and administrative functions. More specialized facilities, such as advanced laboratories and cGMP manufacturing suites for their NK cell therapies, were primarily located at their San Diego site.

Work Culture:

As a clinical-stage biotechnology firm, the work culture at NantKwest was likely characterized by intense research focus, innovation, and a fast-paced environment. Employees were driven by a strong mission to develop scientific breakthroughs for patients with critical unmet medical needs.

HQ Significance:

The headquarters was the nerve center for NantKwest's strategic direction and operational management in its pioneering work on NK cell therapies before its strategic combination with ImmunityBio.

Values Reflected in HQ: The headquarters and operations embodied values of scientific innovation, commitment to addressing challenging diseases, and a drive to translate cutting-edge research into tangible patient benefits.

Location:

Before merging with ImmunityBio, NantKwest's core operations, including R&D, manufacturing, and corporate functions, were predominantly based in the United States, particularly in California. Its international engagement was primarily through strategic collaborations and clinical trials conducted in various countries to evaluate the efficacy and safety of its novel NK cell therapies on a global scale.

Street Address:

9920 Jefferson Boulevard

City:

Culver City

State/Province:

CA

Country:

USA

NantKwest's Global Presence

San Diego, CA/USA

Address: 3530 John Hopkins Court, San Diego, CA 92121

Leveraged San Diego's prominent biotechnology cluster, providing access to a skilled talent pool, research collaborations, and specialized infrastructure vital for advancing NantKwest's innovative immunotherapy pipeline.

Buying Intent Signals for NantKwest

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of NantKwest

As of April 2025, NantKwest' leadership includes:

Dr. Patrick Soon-Shiong - Chairman and Chief Executive Officer
Sonja Nelson - Chief Financial Officer (until February 2021)
Barry J. Simon, M.D. - President and Chief Administrative Officer

Investors of NantKwest

NantKwest has been backed by several prominent investors over the years, including:

Dr. Patrick Soon-Shiong (via affiliated entities)
Public Shareholders (NantKwest was publicly traded on NASDAQ as NK)
Celgene Corporation (made a strategic equity investment and collaboration)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits1

In the year leading up to its merger with ImmunityBio (completed March 2021), NantKwest's executive team saw transitions mainly related to the upcoming combination. The primary standalone change was the departure of its CFO. Post-merger, a new leadership structure was formed for the combined entity, ImmunityBio.

Departures

Sonja Nelson, Sonja Nelson departed her role as Chief Financial Officer of NantKwest prior to the finalization of the merger with ImmunityBio.

New Appointments:

Dr. Patrick Soon-Shiong, Assumed the role of Executive Chairman for the combined company, ImmunityBio, following the merger of NantKwest and ImmunityBio.
Richard Adcock, Became Chief Financial Officer of the combined company, ImmunityBio. He previously served as ImmunityBio's CFO prior to the merger.

Technology (Tech Stack) used by NantKwest

Discover the tools NantKwest uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

NantKwest Email Formats and Examples

NantKwest is now part of ImmunityBio, and its nantkwest.com email domain is no longer in active use for new communications. Historically, NantKwest likely utilized common corporate email patterns. For ImmunityBio, refer to their current email format.

Common historical patterns for NantKwest might have included [first_initial][last_name]@nantkwest.com (e.g., jdoe@nantkwest.com) or [first_name].[last_name]@nantkwest.com (e.g., jane.doe@nantkwest.com).

Format

jsmith@nantkwest.com

Example

0%

Success rate

News and media

GlobeNewswireDecember 21, 2020

NantKwest News: ImmunityBio and NantKwest to Combine, Creating a Leading Immunotherapy and Cell Therapy Company

NantKwest and ImmunityBio announced a definitive agreement for an all-stock merger. The combination aimed to create a leading immunotherapy and cell therapy company by integrating NantKwest's natural killer cell platform with ImmunityBio's diverse immunotherapy pipeline, with Dr. Patrick Soon-Shiong to lead as Executive Chairman....more

Business WireNovember 8, 2019

NantKwest News: NantKwest Reports Third Quarter 2019 Financial Results and Provides Clinical Update

NantKwest released its Q3 2019 financial results and provided updates on its clinical programs. Highlights included progress on its haNK cell therapy in combination treatments for various cancers and advancements in its off-the-shelf NK cell platform development, underscoring its commitment to advancing novel immunotherapies....more

PR NewswireJuly 28, 2015

NantKwest News: NantKwest Prices Initial Public Offering

NantKwest announced the pricing of its initial public offering (IPO) of 8,295,000 shares of common stock at a price of $25.00 per share. The shares began trading on the Nasdaq Global Select Market under the ticker symbol 'NK'. This IPO marked a significant milestone for the company in funding its innovative NK cell therapy research....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including NantKwest, are just a search away.